Processa pharmaceuticals schedules conference call to discuss second quarter results and provide drug development update on august 12 at 5:30 p.m. est

Hanover, md., aug. 06, 2021 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need condition announces today it will host a conference call and live webcast on august 12, 2021, at 5:30 p.m. est to discuss its second quarter 2021 results and provide an update on its clinical pipeline.
PCSA Ratings Summary
PCSA Quant Ranking